Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in irrigation fluid at different temperatures during TURP
IRCT20230521058247N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tranexamic acid in benign prostatic hyperplasia (BPH) (4 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Bleeding and Shivering. Started May 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20230521058247N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230521058247N1.